Today news
About the same in other media
EU grants fast-track assessment to AstraZeneca’s COVID-19 prevention drug
Reading now: 437
financialexpress.comAstraZeneca on Monday announced that the EU drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, Sipavibart, under an accelerated assessment.
According to the company’s press statement, the submission was based on positive data from a late-stage trial that showed the drug helped reduce the incidence of COVID-19 in immunocompromised patients.
(With inputs from Reuters)
Read more on financialexpress.comAbout this in other media
Physical inactivity a ‘silent threat’ as countries, including Canada, off track globalnews.ca /1 week ago
Arvind Kejriwal may not be out of Tihar jail even if SC grants him bail today. Here's why livemint.com /1 week ago
South Korean rescuers search burned factory after a blaze killed 22, mostly Chinese migrants abcnews.go.com /1 week ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
